Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1557-1904

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease ; day:13 ; month:2 ; year:2019 ; pages:1-14
Journal of neuroImmune pharmacology ; (13.2.2019), 1-14

Creator: Keaney, James
Gasser, Julien
Gillet, Gaëlle
Scholz, Diana
Kadiu, Irena

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11481-019-09839-0

URN: urn:nbn:de:101:1-2019031522101506542459

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:55 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Keaney, James
Gasser, Julien
Gillet, Gaëlle
Scholz, Diana
Kadiu, Irena
SpringerLink (Online service)

Other Objects (12)

Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways

Synthesis of a Bruton’s Tyrosine Kinase Inhibitor

Editorial: Targeting bruton tyrosine kinase

Bruton´s tyrosine kinase-mediated NLRP3 phosphorylation promotes inflammasome activation

Role of Bruton’s tyrosine kinase in B cells and malignancies

Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances

Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis

PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases

Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

Second-generation inhibitors of Bruton tyrosine kinase

Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways

Synthesis of a Bruton’s Tyrosine Kinase Inhibitor

Editorial: Targeting bruton tyrosine kinase

Bruton´s tyrosine kinase-mediated NLRP3 phosphorylation promotes inflammasome activation

Role of Bruton’s tyrosine kinase in B cells and malignancies

Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances

Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis

PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases

Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

Second-generation inhibitors of Bruton tyrosine kinase

Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways

Synthesis of a Bruton’s Tyrosine Kinase Inhibitor

Editorial: Targeting bruton tyrosine kinase

Bruton´s tyrosine kinase-mediated NLRP3 phosphorylation promotes inflammasome activation

Role of Bruton’s tyrosine kinase in B cells and malignancies

Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances

Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis

PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases

Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

Second-generation inhibitors of Bruton tyrosine kinase

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Inhibition of Bruton’s Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer’s Disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways

Synthesis of a Bruton’s Tyrosine Kinase Inhibitor

Editorial: Targeting bruton tyrosine kinase

Bruton´s tyrosine kinase-mediated NLRP3 phosphorylation promotes inflammasome activation

Role of Bruton’s tyrosine kinase in B cells and malignancies

Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances

Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis

PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases

Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

Second-generation inhibitors of Bruton tyrosine kinase

Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways

Synthesis of a Bruton’s Tyrosine Kinase Inhibitor

Editorial: Targeting bruton tyrosine kinase

Bruton´s tyrosine kinase-mediated NLRP3 phosphorylation promotes inflammasome activation

Role of Bruton’s tyrosine kinase in B cells and malignancies

Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances

Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis

PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases

Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

Second-generation inhibitors of Bruton tyrosine kinase

Fenebrutinib, a Bruton’s tyrosine kinase inhibitor, blocks distinct human microglial signaling pathways

Synthesis of a Bruton’s Tyrosine Kinase Inhibitor

Editorial: Targeting bruton tyrosine kinase

Bruton´s tyrosine kinase-mediated NLRP3 phosphorylation promotes inflammasome activation

Role of Bruton’s tyrosine kinase in B cells and malignancies

Inhibitors targeting Bruton’s tyrosine kinase in cancers: drug development advances

Bruton’s tyrosine kinase inhibition ameliorated neuroinflammation during chronic white matter ischemia

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis

PROTAC for Bruton’s tyrosine kinase degradation alleviates inflammation in autoimmune diseases

Correction to: Role of Bruton’s tyrosine kinase in B cells and malignancies

Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease

Second-generation inhibitors of Bruton tyrosine kinase

Related objects

Reset password